2013 Fiscal Year Final Research Report
New development of pancreatic cancer stromal control based on the molecular analysis
Project/Area Number |
24791430
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Digestive surgery
|
Research Institution | Kyushu University |
Principal Investigator |
FUJITA Hayato 九州大学, 医学(系)研究科(研究院), 共同研究員 (40611281)
|
Project Period (FY) |
2012-04-01 – 2014-03-31
|
Keywords | 膵癌 / 間葉系幹細胞 / 線維増生 |
Research Abstract |
CD90-positive fibroblasts were observed in 93% or more in the analysis of pancreatic stellate cells and this CD90 could be the key surface marker to regulate desmoplasia. In the analysis of pancreatic cancer cells, CD105-positive pancreatic cancer cells showed the specific gene expression of epithelial-mesenchymal transition and these mobility were enhanced by pancreatic stellate cells. In the case of CD166, CD166-negative pancreatic cancer cells showed strong mobility and invasiveness compared with CD166-positive cells. Furthermore, the anti-fibrotic drug "Pirfenidone" inhibited pancreatic cancer desmoplasia mainly contributed by pancreatic stellate cells and it had been suggested that regulation of stroma could suppress progression for pancreatic cancer.
|
Research Products
(6 results)
-
-
-
[Journal Article] CD271+ subpopulation of pancreatic stellate cells correlates with prognosis of pancreatic cancer and is regulated by interaction with cancer cells2012
Author(s)
Fujiwara K, Ohuchida K, Mizumoto K, Shindo K, Eguchi D, Kozono S, Ikenaga N, Ohtsuka T, Takahata S, Aishima S, Tanaka M
-
Journal Title
DOI
-
-
-